skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: Wiley Online Library All Journals remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update
Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update

Hicks, J K ; Sangkuhl, K ; Swen, J J ; Ellingrod, V L ; Müller, D J ; Shimoda, K ; Bishop, J R ; Kharasch, E D ; Skaar, T C ; Gaedigk, A ; Dunnenberger, H M ; Klein, T E ; Caudle, K E ; Stingl, J C

Clinical pharmacology and therapeutics, 2017-07, Vol.102 (1), p.37-44 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
2
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors

Hicks, JK ; Bishop, JR ; Sangkuhl, K ; Müller, DJ ; Ji, Y ; Leckband, SG ; Leeder, JS ; Graham, RL ; Chiulli, DL ; LLerena, A ; Skaar, TC ; Scott, SA ; Stingl, JC ; Klein, TE ; Caudle, KE ; Gaedigk, A

Clinical pharmacology and therapeutics, 2015-08, Vol.98 (2), p.127-134 [Periódico revisado por pares]

United States: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
3
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants

Bousman, Chad A. ; Stevenson, James M. ; Ramsey, Laura B. ; Sangkuhl, Katrin ; Hicks, J. Kevin ; Strawn, Jeffrey R. ; Singh, Ajeet B. ; Ruaño, Gualberto ; Mueller, Daniel J. ; Tsermpini, Evangelia Eirini ; Brown, Jacob T. ; Bell, Gillian C. ; Leeder, J. Steven ; Gaedigk, Andrea ; Scott, Stuart A. ; Klein, Teri E. ; Caudle, Kelly E. ; Bishop, Jeffrey R.

Clinical pharmacology and therapeutics, 2023-07, Vol.114 (1), p.51-68 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
4
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants

Hicks, J K ; Swen, J J ; Thorn, C F ; Sangkuhl, K ; Kharasch, E D ; Ellingrod, V L ; Skaar, T C ; Müller, D J ; Gaedigk, A ; Stingl, J C

Clinical pharmacology and therapeutics, 2013-05, Vol.93 (5), p.402-408 [Periódico revisado por pares]

Basingstoke: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
5
Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update
Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update

Hicks, JK ; Sangkuhl, K ; Swen, JJ ; Ellingrod, VL ; Müller, DJ ; Shimoda, K ; Bishop, JR ; Kharasch, ED ; Skaar, TC ; Gaedigk, A ; Dunnenberger, HM ; Klein, TE ; Caudle, KE ; Stingl, JC

Clinical pharmacology and therapeutics, 2017-07, Vol.102 (1), p.37-44 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
6
Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing: 2013 Update
Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing: 2013 Update
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing: 2013 Update

Relling, M V ; Gardner, E E ; Sandborn, W J ; Schmiegelow, K ; Pui, C-H ; Yee, S W ; Stein, C M ; Carrillo, M ; Evans, W E ; Hicks, J K ; Schwab, M ; Klein, T E

Clinical pharmacology and therapeutics, 2013-04, Vol.93 (4), p.324-325 [Periódico revisado por pares]

Basingstoke: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
7
Pharmacogenomics and Individualized Medicine: Translating Science Into Practice
Pharmacogenomics and Individualized Medicine: Translating Science Into Practice
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pharmacogenomics and Individualized Medicine: Translating Science Into Practice

Crews, K R ; Hicks, J K ; Pui, C-H ; Relling, M V ; Evans, W E

Clinical pharmacology and therapeutics, 2012-10, Vol.92 (4), p.467-475 [Periódico revisado por pares]

United States: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
8
A prospective randomized multicentre study of the impact of gallium‐68 prostate‐specific membrane antigen (PSMA) PET/CT imaging for staging high‐risk prostate cancer prior to curative‐intent surgery or radiotherapy (proPSMA study): clinical trial protocol
A prospective randomized multicentre study of the impact of gallium‐68 prostate‐specific membrane antigen (PSMA) PET/CT imaging for staging high‐risk prostate cancer prior to curative‐intent surgery or radiotherapy (proPSMA study): clinical trial protocol
Material Type:
Artigo 		Adicionar ao Meu Espaço

A prospective randomized multicentre study of the impact of gallium‐68 prostate‐specific membrane antigen (PSMA) PET/CT imaging for staging high‐risk prostate cancer prior to curative‐intent surgery or radiotherapy (proPSMA study): clinical trial protocol

Hofman, Michael S. ; Murphy, Declan G. ; Williams, Scott G. ; Nzenza, Tatenda ; Herschtal, Alan ; Lourenco, Richard De Abreu ; Bailey, Dale L. ; Budd, Ray ; Hicks, Rodney J. ; Francis, Roslyn J. ; Lawrentschuk, Nathan

BJU international, 2018-11, Vol.122 (5), p.783-793 [Periódico revisado por pares]

England: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
9
The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Overcoming Challenges of Real-World Implementation
The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Overcoming Challenges of Real-World Implementation
Material Type:
Artigo 		Adicionar ao Meu Espaço

The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Overcoming Challenges of Real-World Implementation

Shuldiner, A R ; Relling, M V ; Peterson, J F ; Hicks, K ; Freimuth, R R ; Sadee, W ; Pereira, N L ; Roden, D M ; Johnson, J A ; Klein, T E

Clinical pharmacology and therapeutics, 2013-08, Vol.94 (2), p.207-210 [Periódico revisado por pares]

Basingstoke: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
10
Response to the FDA Decision Regarding DPYD Testing Prior to Fluoropyrimidine Chemotherapy
Response to the FDA Decision Regarding DPYD Testing Prior to Fluoropyrimidine Chemotherapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Response to the FDA Decision Regarding DPYD Testing Prior to Fluoropyrimidine Chemotherapy

Hertz, Daniel L. ; Smith, D. Max ; Scott, Stuart A. ; Patel, Jai N. ; Hicks, J. Kevin

Clinical pharmacology and therapeutics, 2023-10, Vol.114 (4), p.768-779 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (598)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (526)
  2. Resenhas  (123)
  3. Reports  (7)
  4. Anais de Congresso  (1)
  5. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1960  (199)
  2. 1960Até1977  (47)
  3. 1978Até1993  (40)
  4. 1994Até2008  (166)
  5. Após 2008  (206)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (656)
  2. Japonês  (56)
  3. Francês  (1)
  4. Alemão  (1)
  5. Norueguês  (1)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.